MedAvail Holdings (MDVLQ) Ratios
MedAvail Holdings Ratios
MDVLQ's free cash flow for Q2 2023 was $-4.47M. For the 2023 fiscal year, MDVLQ's free cash flow was decreased by $-92.00K and operating cash flow was $-4.38M. See a summary of the company’s cash flow.
| Ratios | Mar 23 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 4.03 | 3.65 | 8.39 | 1.84 | 1.78 |
| Quick Ratio | 2.86 | 3.13 | 8.02 | 1.24 | 0.75 |
| Cash Ratio | 1.93 | 2.62 | 7.61 | 1.15 | 0.01 |
| Solvency Ratio | -3.49 | -2.16 | -3.03 | -0.17 | -1.71 |
| Operating Cash Flow Ratio | -8.02 | -5.67 | -3.76 | -2.55 | -1.99 |
| Short-Term Operating Cash Flow Coverage | -67.32 | -62.34 | -13.25 | 0.00 | -3.20 |
| Net Current Asset Value | $ 11.62M | $ 8.31M | $ 55.60M | $ -100.56M | $ 1.27M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.21 | 0.32 | 0.05 | 0.75 | 0.23 |
| Debt-to-Equity Ratio | 0.34 | 0.64 | 0.06 | -0.14 | 0.36 |
| Debt-to-Capital Ratio | 0.25 | 0.39 | 0.05 | -0.16 | 0.26 |
| Long-Term Debt-to-Capital Ratio | 0.19 | 0.33 | 0.00 | -0.15 | 0.00 |
| Financial Leverage Ratio | 1.59 | 2.00 | 1.14 | -0.19 | 1.58 |
| Debt Service Coverage Ratio | -22.23 | -31.98 | -6.99 | -26.10 | -2.69 |
| Interest Coverage Ratio | -39.61 | -73.87 | -16.77 | -28.40 | -270.56 |
| Debt to Market Cap | 0.28 | 0.22 | 0.03 | 0.35 | 0.15 |
| Interest Debt Per Share | 6.27 | 19.65 | 41.23 | 226.39 | 86.65 |
| Net Debt to EBITDA | 0.10 | 0.18 | 2.29 | -0.25 | -0.26 |
| Profitability Margins | |||||
| Gross Profit Margin | 6.00% | 1.43% | 36.96% | 25.14% | -565.56% |
| EBIT Margin | -107.68% | -195.33% | -183.05% | -551.55% | -1203.06% |
| EBITDA Margin | -96.88% | -183.68% | -170.13% | -508.01% | -1083.06% |
| Operating Profit Margin | -107.69% | -196.62% | -148.99% | -552.74% | -1202.50% |
| Pretax Profit Margin | -110.40% | -197.99% | -191.94% | -571.02% | -1207.50% |
| Net Profit Margin | -110.45% | -198.00% | -191.94% | -571.02% | -895.28% |
| Continuous Operations Profit Margin | -110.45% | -198.00% | -191.94% | -571.02% | -895.28% |
| Net Income Per EBT | 100.05% | 100.00% | 100.00% | 100.00% | 74.14% |
| EBT Per EBIT | 102.52% | 100.70% | 128.83% | 103.31% | 100.42% |
| Return on Assets (ROA) | -143.72% | -114.87% | -38.67% | -119.61% | -72.35% |
| Return on Equity (ROE) | -228.66% | -229.72% | -43.90% | 22.28% | -114.25% |
| Return on Capital Employed (ROCE) | -170.73% | -142.01% | -33.72% | -201.82% | -153.46% |
| Return on Invested Capital (ROIC) | -162.27% | -135.96% | -32.24% | -192.04% | -83.67% |
| Return on Tangible Assets | -145.76% | -122.24% | -38.80% | -120.07% | -72.35% |
| Earnings Yield | -241.46% | -95.84% | -31.13% | -59.91% | -47.61% |
| Efficiency Ratios | |||||
| Receivables Turnover | 19.52 | 18.61 | 9.19 | 9.06 | 0.30 |
| Payables Turnover | 24.19 | 8.81 | 6.58 | 6.90 | 10.15 |
| Inventory Turnover | 5.84 | 5.57 | 3.13 | 0.61 | 1.43 |
| Fixed Asset Turnover | 5.05 | 2.69 | 2.77 | 1.00 | 2.42 |
| Asset Turnover | 1.30 | 0.58 | 0.20 | 0.21 | 0.08 |
| Working Capital Turnover Ratio | 2.28 | 0.58 | 0.45 | 0.98 | 0.19 |
| Cash Conversion Cycle | 66.10 | 43.69 | 100.99 | 581.37 | 1438.06 |
| Days of Sales Outstanding | 18.70 | 19.61 | 39.72 | 40.27 | 1218.69 |
| Days of Inventory Outstanding | 62.48 | 65.53 | 116.78 | 593.98 | 255.32 |
| Days of Payables Outstanding | 15.09 | 41.45 | 55.51 | 52.88 | 35.95 |
| Operating Cycle | 81.19 | 85.14 | 156.49 | 634.25 | 1474.01 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -36.23 | -65.10 | -250.21 | -309.42 | -273.16 |
| Free Cash Flow Per Share | -37.98 | -70.14 | -257.35 | -315.79 | -273.16 |
| Dividend Paid and CapEx Coverage Ratio | -20.69 | -12.93 | -35.05 | -48.62 | 0.00 |
| Capital Expenditure Coverage Ratio | -20.69 | -12.93 | -35.05 | -48.62 | 0.00 |
| Operating Cash Flow Coverage Ratio | -6.74 | -3.47 | -8.24 | -1.44 | -3.20 |
| Operating Cash Flow to Sales Ratio | -1.11 | -1.92 | -2.05 | -5.18 | -9.03 |
| Free Cash Flow Yield | -253.39% | -100.20% | -34.20% | -55.50% | -48.01% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -0.41 | -1.04 | -3.21 | -1.67 | -2.10 |
| Price-to-Sales (P/S) Ratio | 0.46 | 2.07 | 6.17 | 9.53 | 18.81 |
| Price-to-Book (P/B) Ratio | 0.95 | 2.40 | 1.41 | -0.37 | 2.40 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -0.39 | -1.00 | -2.92 | -1.80 | -2.08 |
| Price-to-Operating Cash Flow Ratio | -0.41 | -1.08 | -3.01 | -1.84 | -2.08 |
| Price-to-Earnings Growth (PEG) Ratio | 0.01 | 0.01 | 0.10 | -0.06 | 0.06 |
| Enterprise Value Multiple | -0.37 | -0.94 | -1.33 | -2.13 | -1.99 |
| Enterprise Value | 15.35M | 38.28M | 31.66M | 40.72M | 7.77M |
| EV to EBITDA | -0.37 | -0.94 | -1.33 | -2.13 | -1.99 |
| EV to Sales | 0.36 | 1.73 | 2.27 | 10.80 | 21.58 |
| EV to Free Cash Flow | -0.31 | -0.84 | -1.07 | -2.04 | -2.39 |
| EV to Operating Cash Flow | -0.32 | -0.90 | -1.11 | -2.08 | -2.39 |
| Tangible Book Value Per Share | 15.48 | 25.68 | 531.63 | -1531.05 | 237.10 |
| Shareholders’ Equity Per Share | 15.83 | 29.20 | 533.62 | -1529.94 | 237.10 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.00 | -0.00 | 0.00 | 0.00 | 0.26 |
| Revenue Per Share | 32.77 | 33.88 | 122.06 | 59.70 | 30.26 |
| Net Income Per Share | -36.20 | -67.09 | -234.27 | -340.88 | -270.89 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 0.74 |
| Interest Burden | 1.03 | 1.01 | 1.05 | 1.04 | 1.00 |
| Research & Development to Revenue | 0.03 | 0.04 | 0.05 | 0.29 | 1.16 |
| SG&A to Revenue | 0.97 | 1.75 | 1.66 | 4.12 | 0.00 |
| Stock-Based Compensation to Revenue | 0.05 | 0.05 | 0.03 | 0.09 | 0.00 |
| Income Quality | 1.00 | 0.97 | 1.07 | 0.91 | 1.01 |
Currency in USD
